297 related articles for article (PubMed ID: 30481277)
41. Pathogenesis of Sjögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy.
van Blokland SC; Versnel MA
Clin Immunol; 2002 May; 103(2):111-24. PubMed ID: 12027416
[No Abstract] [Full Text] [Related]
42. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
43. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
Jabs DA; Enger C; Prendergast RA
Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
[TBL] [Abstract][Full Text] [Related]
44. Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjögren's syndrome (SJS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse.
Nguyen CQ; Sharma A; She JX; McIndoe RA; Peck AB
Exp Eye Res; 2009 Mar; 88(3):398-409. PubMed ID: 19103199
[TBL] [Abstract][Full Text] [Related]
45. Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren's syndrome.
Chen FY; Lee A; Ge S; Nathan S; Knox SM; McNamara NA
PLoS One; 2017; 12(9):e0184916. PubMed ID: 28926640
[TBL] [Abstract][Full Text] [Related]
46. Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains.
Jabs DA; Prendergast RA
Invest Ophthalmol Vis Sci; 1988 Sep; 29(9):1437-43. PubMed ID: 3047079
[TBL] [Abstract][Full Text] [Related]
47. Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjögren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis?
van Blokland SC; van Helden-Meeuwsen CG; Wierenga-Wolf AF; Drexhage HA; Hooijkaas H; van de Merwe JP; Versnel MA
Lab Invest; 2000 Apr; 80(4):575-85. PubMed ID: 10780673
[TBL] [Abstract][Full Text] [Related]
48. Role of T cells in the pathogenesis of autoimmune lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Lee B; Prendergast RA
Curr Eye Res; 1997 Sep; 16(9):909-16. PubMed ID: 9288452
[TBL] [Abstract][Full Text] [Related]
49. Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia.
Zoukhri D; Hodges RR; Byon D; Kublin CL
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1429-36. PubMed ID: 11980857
[TBL] [Abstract][Full Text] [Related]
50. Lacrimal gland fluid secretion and lymphocytic infiltration in the NZB/W mouse model of Sjögren's syndrome.
Paranyuk Y; Claros N; Birzgalis A; Moore LC; Brink PR; Walcott B
Curr Eye Res; 2001 Sep; 23(3):199-205. PubMed ID: 11803482
[TBL] [Abstract][Full Text] [Related]
51. Influence of sex on gene expression in the mouse lacrimal gland.
Richards SM; Jensen RV; Liu M; Sullivan BD; Lombardi MJ; Rowley P; Schirra F; Treister NS; Suzuki T; Steagall RJ; Yamagami H; Sullivan DA
Exp Eye Res; 2006 Jan; 82(1):13-23. PubMed ID: 15979613
[TBL] [Abstract][Full Text] [Related]
52. Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
Lieberman SM; Kreiger PA; Koretzky GA
Immunology; 2015 Jun; 145(2):232-41. PubMed ID: 25581706
[TBL] [Abstract][Full Text] [Related]
53. Review of genes potentially related to hyposecretion in male non-obese diabetic (NOD) mice, a Sjögren's syndrome model.
Ohno Y; Satoh K; Kashimata M
J Oral Biosci; 2023 Sep; 65(3):211-217. PubMed ID: 37209839
[TBL] [Abstract][Full Text] [Related]
54. The Effect of Mesenchymal Stem Cells on Dry Eye in Sjogren Syndrome Mouse Model.
Shin S; Yoon SG; Kim M; Cheon EJ; Jeon Y; Lee HJ; Chung SH
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674547
[TBL] [Abstract][Full Text] [Related]
55. Age-Related Conjunctival Disease in the C57BL/6.NOD-Aec1Aec2 Mouse Model of Sjögren Syndrome Develops Independent of Lacrimal Dysfunction.
You IC; Bian F; Volpe EA; de Paiva CS; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2224-33. PubMed ID: 25758816
[TBL] [Abstract][Full Text] [Related]
56. Androgen control of autoimmune expression in lacrimal glands of MRL/Mp-lpr/lpr mice.
Ariga H; Edwards J; Sullivan DA
Clin Immunol Immunopathol; 1989 Dec; 53(3):499-508. PubMed ID: 2805454
[TBL] [Abstract][Full Text] [Related]
57. Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice.
Jabs DA; Prendergast RA; Campbell AL; Lee B; Akpek EK; Gérard HC; Hudson AP; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5624-9. PubMed ID: 18055812
[TBL] [Abstract][Full Text] [Related]
58. Absence of 4 1BB gene function exacerbates lacrimal gland inflammation in autoimmune-prone MRL-Faslpr mice.
Vinay DS; Kim JD; Asai T; Choi BK; Kwon BS
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4608-15. PubMed ID: 17898284
[TBL] [Abstract][Full Text] [Related]
59. Arginase 1 is involved in lacrimal hyposecretion in male NOD mice, a model of Sjögren's syndrome, regardless of dacryoadenitis status.
Ohno Y; Satoh K; Shitara A; Into T; Kashimata M
J Physiol; 2020 Nov; 598(21):4907-4925. PubMed ID: 32780506
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.
Park E; Kim D; Lee SM; Jun HS
Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
